Angion Biomedica Company
Angion Biomedica is a clinical stage organ restoration biopharmaceutical company focused on renal disease.
Industry:
Biopharma, Biotechnology, Medical
Investors Number:
2
Technology:
Data-driven Technologies
Investor Type:
IPO
Last Funding Type:
Post-IPO Equity
Total Funding:
44356452
Funding Status:
IPO
Headquarters:
Uniondale, New York, United States
Founded Date:
1998
Employee Number:
11-50
Last Funding Date:
2021
Estimated Revenue:
$10M to $50M